{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:03:48Z","timestamp":1789506228581,"version":"build-2803163510"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00277-024-05630-1","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:02:06Z","timestamp":1707782526000},"page":"1819-1831","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Coagulation and Inflammation in COVID-19: Reciprocal Relationship between Inflammatory and Coagulation Markers"],"prefix":"10.1007","volume":"103","author":[{"given":"Rasoul","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Nasri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Kalantari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,13]]},"reference":[{"issue":"6","key":"5630_CR1","doi-asserted-by":"publisher","first-page":"105948","DOI":"10.1016\/j.ijantimicag.2020.105948","volume":"55","author":"L Wang","year":"2020","unstructured":"Wang L, Wang Y, Ye D, Liu Q (2020) Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents 55(6):105948","journal-title":"Int J Antimicrob Agents"},{"issue":"10223","key":"5630_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506","journal-title":"Lancet"},{"issue":"6","key":"5630_CR3","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/apa.15270","volume":"109","author":"JF Ludvigsson","year":"2020","unstructured":"Ludvigsson JF (2020) Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr 109(6):1088\u20131095","journal-title":"Acta Paediatr"},{"issue":"13","key":"5630_CR4","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu Z, McGoogan JM (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72\u00a0314 cases from the Chinese Center for Disease Control and Prevention. Jama 323(13):1239\u20131242","journal-title":"Jama"},{"issue":"4","key":"5630_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.30714\/j-ebr.2020463629","volume":"3","author":"G Aktas","year":"2020","unstructured":"Aktas G (2020) A comprehensive review on rational and effective treatment strategies against an invisible enemy; SARS Cov-2 infection. Exp Biomed Res 3(4):293\u2013311","journal-title":"Exp Biomed Res"},{"issue":"3","key":"5630_CR6","first-page":"96","volume":"2","author":"G Aktas","year":"2022","unstructured":"Aktas G, Balci B, Yilmaz S, Bardak H, Duman TT, Civil C (2022) Characteristics of Covid-19 infection with the original SARS-Cov-2 virus and other variants: a comparative review. J Bionic Mem 2(3):96\u2013112","journal-title":"J Bionic Mem"},{"issue":"7","key":"5630_CR7","first-page":"831","volume":"14","author":"RSY Wong","year":"2021","unstructured":"Wong RSY (2021) Inflammation in COVID-19: from pathogenesis to treatment. Int J Clin Exp Pathol 14(7):831\u2013844","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"5630_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/16078454.2021.1950898","volume":"26","author":"A Khalid","year":"2021","unstructured":"Khalid A, Ali Jaffar M, Khan T, Abbas Lail R, Ali S, Aktas G et al (2021) Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis. Hematology 26(1):529\u2013542","journal-title":"Hematology"},{"key":"5630_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/1806-9282.67.suppl1.20200678","volume":"67","author":"G Aktas","year":"2021","unstructured":"Aktas G (2021) Hematological predictors of novel coronavirus infection. Rev Assoc Med Bras 67:1\u20132","journal-title":"Rev Assoc Med Bras"},{"issue":"10","key":"5630_CR10","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.5858\/arpa.2020-0324-SA","volume":"144","author":"Y Fei","year":"2020","unstructured":"Fei Y, Tang N, Liu H, Cao W (2020) Coagulation dysfunctiona hallmark in COVID-19. Arch Pathol Lab Med 144(10):1223\u20131229","journal-title":"Arch Pathol Lab Med"},{"key":"5630_CR11","doi-asserted-by":"publisher","first-page":"100761","DOI":"10.1016\/j.blre.2020.100761","volume":"47","author":"T Hadid","year":"2021","unstructured":"Hadid T, Kafri Z, Al-Katib A (2021) Coagulation and anticoagulation in COVID-19. Blood Rev 47:100761","journal-title":"Blood Rev"},{"issue":"6","key":"5630_CR12","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1080\/10408363.2020.1770685","volume":"57","author":"G Ponti","year":"2020","unstructured":"Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T (2020) Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci 57(6):389\u2013399","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"5630_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11239-020-02107-6","volume":"50","author":"RC Becker","year":"2020","unstructured":"Becker RC (2020) Toward understanding the 2019 coronavirus and its impact on the heart. J Thromb Thrombolysis 50(1):33\u201342","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"5630_CR14","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.cell.2020.11.032","volume":"183","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D (2020) Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 183(6):1735","journal-title":"Cell"},{"key":"5630_CR15","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.antiviral.2017.11.001","volume":"149","author":"J Lei","year":"2018","unstructured":"Lei J, Kusov Y, Hilgenfeld R (2018) Nsp3 of coronaviruses: structures and functions of a large multi-domain protein. Antivir Res 149:58\u201374","journal-title":"Antivir Res"},{"issue":"7798","key":"5630_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273","journal-title":"Nature"},{"issue":"11","key":"5630_CR17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew FY, Girard JP, Turnquist HR (2016) Interleukin-33 in health and disease. Nat Rev Immunol 16(11):676\u2013689","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"5630_CR18","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12619","volume":"281","author":"C Cayrol","year":"2018","unstructured":"Cayrol C, Girard JP (2018) Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family. Immunol Rev 281(1):154\u2013168","journal-title":"Immunol Rev"},{"issue":"6","key":"5630_CR19","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41423-021-00685-w","volume":"18","author":"Y Liang","year":"2021","unstructured":"Liang Y, Ge Y, Sun J (2021) IL-33 in COVID-19: friend or foe? Cell Mol Immunol 18(6):1602\u20131604","journal-title":"Cell Mol Immunol"},{"key":"5630_CR20","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3389\/fimmu.2019.00692","volume":"10","author":"A Gabryelska","year":"2019","unstructured":"Gabryelska A, Kuna P, Antczak A, Bia\u0142asiewicz P, Panek M (2019) IL-33 Mediated inflammation in chronic respiratory diseases-understanding the role of the member of IL-1 superfamily. Front Immunol 10:692","journal-title":"Front Immunol"},{"issue":"8","key":"5630_CR21","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S2213-2600(20)30222-8","volume":"8","author":"P Spagnolo","year":"2020","unstructured":"Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Casa GD et al (2020) Pulmonary fibrosis secondary to COVID-19: a call to arms? Lancet Respir Med 8(8):750\u2013752","journal-title":"Lancet Respir Med"},{"issue":"36","key":"5630_CR22","doi-asserted-by":"publisher","first-page":"26369","DOI":"10.1074\/jbc.M704916200","volume":"282","author":"H Hayakawa","year":"2007","unstructured":"Hayakawa H, Hayakawa M, Kume A, Tominaga S (2007) Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 282(36):26369\u201326380","journal-title":"J Biol Chem"},{"key":"5630_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.3389\/fimmu.2017.00475","volume":"8","author":"B Griesenauer","year":"2017","unstructured":"Griesenauer B, Paczesny S (2017) The ST2\/IL-33 axis in immune cells during inflammatory diseases. Front Immunol 8:475","journal-title":"Front Immunol"},{"key":"5630_CR24","doi-asserted-by":"crossref","unstructured":"Zeng Z, Hong X-Y, Zhou H, Liao F-L, Guo S, Li Y et al (2020) Serum soluble ST2 as a novel biomarker reflecting inflammatory status and disease severity in patients with COVID-19. Available at SSRN 3594550","DOI":"10.2139\/ssrn.3594550"},{"issue":"7","key":"5630_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","volume":"5","author":"T Guo","year":"2020","unstructured":"Guo T, Fan Y, Chen M, Wu X, Zhang L, He T et al (2020) Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 5(7):811\u2013818","journal-title":"JAMA Cardiol"},{"issue":"17","key":"5630_CR26","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.2217\/bmm-2020-0410","volume":"14","author":"Z Zeng","year":"2020","unstructured":"Zeng Z, Hong XY, Li Y, Chen W, Ye G, Li Y, Luo Y (2020) Serum-soluble ST2 as a novel biomarker reflecting inflammatory status and illness severity in patients with COVID-19. Biomark Med 14(17):1619\u20131629","journal-title":"Biomark Med"},{"issue":"4","key":"5630_CR27","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1172\/JCI114265","volume":"84","author":"M Baggiolini","year":"1989","unstructured":"Baggiolini M, Walz A, Kunkel SL (1989) Neutrophil-activating peptide-1\/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84(4):1045\u20131049","journal-title":"J Clin Invest"},{"issue":"3","key":"5630_CR28","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1084\/jem.173.3.771","volume":"173","author":"F Bazzoni","year":"1991","unstructured":"Bazzoni F, Cassatella MA, Rossi F, Ceska M, Dewald B, Baggiolini M (1991) Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1\/interleukin 8. J Exp Med 173(3):771\u2013774","journal-title":"J Exp Med"},{"key":"5630_CR29","doi-asserted-by":"publisher","first-page":"626235","DOI":"10.3389\/fimmu.2021.626235","volume":"12","author":"A Ma","year":"2021","unstructured":"Ma A, Zhang L, Ye X, Chen J, Yu J, Zhuang L et al (2021) High levels of circulating IL-8 and soluble IL-2R are associated with prolonged illness in patients with severe COVID-19. Front Immunol 12:626235","journal-title":"Front Immunol"},{"issue":"36","key":"5630_CR30","doi-asserted-by":"publisher","first-page":"22351","DOI":"10.1073\/pnas.2010229117","volume":"117","author":"S Kang","year":"2020","unstructured":"Kang S, Tanaka T, Inoue H, Ono C, Hashimoto S, Kioi Y et al (2020) IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome. Proc Natl Acad Sci U S A 117(36):22351\u201322356","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5630_CR31","doi-asserted-by":"crossref","unstructured":"Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA et al (2020) Neutrophil extracellular traps in COVID-19. JCI Insight 5(11).","DOI":"10.1172\/jci.insight.138999"},{"issue":"3","key":"5630_CR32","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","volume":"107","author":"TA Pearson","year":"2003","unstructured":"Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M et al (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3):499\u2013511","journal-title":"Circulation"},{"key":"5630_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1749-6632.1982.tb22124.x","volume":"389","author":"I Kushner","year":"1982","unstructured":"Kushner I (1982) The phenomenon of the acute phase response. Ann N Y Acad Sci 389:39\u201348","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"5630_CR34","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","volume":"107","author":"PM Ridker","year":"2003","unstructured":"Ridker PM (2003) Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107(3):363\u2013369","journal-title":"Circulation"},{"key":"5630_CR35","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1749-6632.1995.tb32318.x","volume":"762","author":"I Kushner","year":"1995","unstructured":"Kushner I, Jiang SL, Zhang D, Lozanski G, Samols D (1995) Do post-transcriptional mechanisms participate in induction of C-reactive protein and serum amyloid A by IL-6 and IL-1? Ann N Y Acad Sci 762:102\u2013107","journal-title":"Ann N Y Acad Sci"},{"issue":"16","key":"5630_CR36","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/01.CIR.0000096055.62724.C5","volume":"108","author":"P Calabr\u00f3","year":"2003","unstructured":"Calabr\u00f3 P, Willerson JT, Yeh ET (2003) Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108(16):1930\u20131932","journal-title":"Circulation"},{"issue":"47","key":"5630_CR37","doi-asserted-by":"publisher","first-page":"48487","DOI":"10.1074\/jbc.R400025200","volume":"279","author":"S Black","year":"2004","unstructured":"Black S, Kushner I, Samols D (2004) C-reactive protein. J Biol Chem 279(47):48487\u201348490","journal-title":"J Biol Chem"},{"issue":"23","key":"5630_CR38","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1093\/eurheartj\/ehaa1103","volume":"42","author":"NR Smilowitz","year":"2021","unstructured":"Smilowitz NR, Kunichoff D, Garshick M, Shah B, Pillinger M, Hochman JS, Berger JS (2021) C-reactive protein and clinical outcomes in patients with COVID-19. Eur Heart J 42(23):2270\u20132279","journal-title":"Eur Heart J"},{"key":"5630_CR39","doi-asserted-by":"publisher","first-page":"175346662093717","DOI":"10.1177\/1753466620937175","volume":"14","author":"I Huang","year":"2020","unstructured":"Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B (2020) C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis 14:1753466620937175","journal-title":"Ther Adv Respir Dis"},{"issue":"6","key":"5630_CR40","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/hep.20720","volume":"41","author":"GJ Quinlan","year":"2005","unstructured":"Quinlan GJ, Martin GS, Evans TW (2005) Albumin: biochemical properties and therapeutic potential. Hepatology 41(6):1211\u20131219","journal-title":"Hepatology"},{"issue":"2","key":"5630_CR41","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/hep.1840080234","volume":"8","author":"MA Rothschild","year":"1988","unstructured":"Rothschild MA, Oratz M, Schreiber SS (1988) Serum albumin. Hepatology 8(2):385\u2013401","journal-title":"Hepatology"},{"key":"5630_CR42","unstructured":"Serum Albumin."},{"issue":"3","key":"5630_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10238-021-00686-z","volume":"21","author":"P Paliogiannis","year":"2021","unstructured":"Paliogiannis P, Mangoni AA, Cangemi M, Fois AG, Carru C, Zinellu A (2021) Serum albumin concentrations are associated with disease severity and outcomes in coronavirus 19 disease (COVID-19): a systematic review and meta-analysis. Clin Exp Med 21(3):343\u2013354","journal-title":"Clin Exp Med"},{"issue":"1","key":"5630_CR44","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10389-020-01309-9","volume":"30","author":"A Bansal","year":"2022","unstructured":"Bansal A, Prasad JB (2022) Liver profile in COVID-19: a meta-analysis. Z Gesundh Wiss 30(1):253\u2013258","journal-title":"Z Gesundh Wiss"},{"issue":"8","key":"5630_CR45","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/hepr.13510","volume":"50","author":"M Parohan","year":"2020","unstructured":"Parohan M, Yaghoubi S, Seraji A (2020) Liver injury is associated with severe coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies. Hepatol Res 50(8):924\u2013935","journal-title":"Hepatol Res"},{"key":"5630_CR46","doi-asserted-by":"crossref","unstructured":"Zhang B, Zhou X, Qiu Y, Song Y, Feng F, Feng J et al (2020) Clinical characteristics of 82 cases of death from COVID-19. PLoS One 15(7):e0235458","DOI":"10.1371\/journal.pone.0235458"},{"issue":"3","key":"5630_CR47","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1590\/1806-9282.20200883","volume":"67","author":"A Torun","year":"1992","unstructured":"Torun A, \u00c7ak\u0131rca TD, \u00c7ak\u0131rca G (1992) Portakal RD (2021) The value of C-reactive protein\/albumin, fibrinogen\/albumin, and neutrophil\/lymphocyte ratios in predicting the severity of CoVID-19. Rev Assoc Med Bras 67(3):431\u2013436","journal-title":"Rev Assoc Med Bras"},{"issue":"10","key":"5630_CR48","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/jcm7100333","volume":"7","author":"JE Park","year":"2018","unstructured":"Park JE, Chung KS, Song JH, Kim SY, Kim EY, Jung JY et al (2018) The C-reactive protein\/albumin ratio as a predictor of mortality in critically ill patients. J Clin Med 7(10):333","journal-title":"J Clin Med"},{"issue":"08","key":"5630_CR49","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3855\/jidc.14826","volume":"15","author":"A Kalabin","year":"2021","unstructured":"Kalabin A, Mani VR, Valdivieso SC, Donaldson B (2021) Does C reactive protein\/albumin ratio have prognostic value in patients with COVID-19. J Infect Dev Ctries 15(08):1086\u20131093","journal-title":"J Infect Dev Ctries"},{"key":"5630_CR50","doi-asserted-by":"crossref","unstructured":"Karagoz I, Ozer B, Ital I, Turkoglu M, Disikirik A, Ozer S (2023) C-reactive protein-to-serum albumin ratio as a marker of prognosis in adult intensive care population. Bratisl Lek Listy 124(4):277\u2013279","DOI":"10.4149\/BLL_2023_042"},{"key":"5630_CR51","doi-asserted-by":"publisher","unstructured":"Aktas G (2023) Serum C-reactive protein to albumin ratio as a reliable marker of diabetic neuropathy in type 2 diabetes mellitus. Preprints. https:\/\/doi.org\/10.20944\/preprints202306.0202.v1","DOI":"10.20944\/preprints202306.0202.v1"},{"issue":"6","key":"5630_CR52","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.pcd.2021.08.015","volume":"15","author":"S Bilgin","year":"2021","unstructured":"Bilgin S, Kurtkulagi O, Tel BMA, Duman TT, Kahveci G, Khalid A, Aktas G (2021) Does C-reactive protein to serum albumin ratio correlate with diabetic nephropathy in patients with type 2 diabetes mellitus? The CARE TIME study. Prim Care Diabetes 15(6):1071\u20131074","journal-title":"Prim Care Diabetes"},{"key":"5630_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2369-12-30","volume":"12","author":"Q Xie","year":"2011","unstructured":"Xie Q, Zhou Y, Xu Z, Yang Y, Kuang D, You H et al (2011) The ratio of CRP to prealbumin levels predict mortality in patients with hospital-acquired acute kidney injury. BMC Nephrol 12:30","journal-title":"BMC Nephrol"},{"issue":"9","key":"5630_CR54","doi-asserted-by":"publisher","first-page":"300060521104611","DOI":"10.1177\/03000605211046112","volume":"49","author":"S Kalyon","year":"2021","unstructured":"Kalyon S, G\u00fcltop F, \u015eim\u015fek F, Ada\u015f M (2021) Relationships of the neutrophil-lymphocyte and CRP-albumin ratios with the duration of hospitalization and fatality in geriatric patients with COVID-19. J Int Med Res 49(9):3000605211046112","journal-title":"J Int Med Res"},{"issue":"6","key":"5630_CR55","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/BF01740811","volume":"25","author":"W Karzai","year":"1997","unstructured":"Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K (1997) Procalcitonin--a new indicator of the systemic response to severe infections. Infection 25(6):329\u2013334","journal-title":"Infection"},{"key":"5630_CR56","first-page":"2017","volume-title":"Antimicrobial resistance: global report on surveillance","author":"Organization WH","year":"2014","unstructured":"Organization WH (2014) Antimicrobial resistance: global report on surveillance. World Health Organization, Geneva, Switzerland, p 2017"},{"issue":"4","key":"5630_CR57","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/ard.62.4.337","volume":"62","author":"I Del\u00e8vaux","year":"2003","unstructured":"Del\u00e8vaux I, Andr\u00e9 M, Colombier M, Albuisson E, Meylheuc F, B\u00e8gue RJ et al (2003) Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 62(4):337\u2013340","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"5630_CR58","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1515\/CCLM.1999.119","volume":"37","author":"S Russwurm","year":"1999","unstructured":"Russwurm S, Wiederhold M, Oberhoffer M, Stonans I, Zipfel PF, Reinhart K (1999) Molecular aspects and natural source of procalcitonin. Clin Chem Lab Med 37(8):789\u2013797","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"5630_CR59","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s12519-020-00354-4","volume":"16","author":"D Sun","year":"2020","unstructured":"Sun D, Li H, Lu XX, Xiao H, Ren J, Zhang FR, Liu ZS (2020) Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: a single center\u2019s observational study. World J Pediatr 16(3):251\u2013259","journal-title":"World J Pediatr"},{"issue":"9","key":"5630_CR60","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/jmv.25810","volume":"92","author":"X Chen","year":"2020","unstructured":"Chen X, Yang Y, Huang M, Liu L, Zhang X, Xu J et al (2020) Differences between COVID-19 and suspected then confirmed SARS-CoV-2-negative pneumonia: a retrospective study from a single center. J Med Virol 92(9):1572\u20131579","journal-title":"J Med Virol"},{"issue":"11","key":"5630_CR61","doi-asserted-by":"publisher","first-page":"e0206527","DOI":"10.1371\/journal.pone.0206527","volume":"13","author":"I Yunus","year":"2018","unstructured":"Yunus I, Fasih A, Wang Y (2018) The use of procalcitonin in the determination of severity of sepsis, patient outcomes and infection characteristics. PLoS One 13(11):e0206527","journal-title":"PLoS One"},{"issue":"1","key":"5630_CR62","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/10408363.2021.1975637","volume":"59","author":"S Wolfisberg","year":"2022","unstructured":"Wolfisberg S, Gregoriano C, Schuetz P (2022) Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-19. Crit Rev Clin Lab Sci 59(1):54\u201365","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"10","key":"5630_CR63","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 6(10):a016295","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"16","key":"5630_CR64","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","volume":"368","author":"SA Grupp","year":"2013","unstructured":"Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, Rheingold SR et al (2013) Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med 368(16):1509\u20131518","journal-title":"N Engl J Med"},{"issue":"1","key":"5630_CR65","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","volume":"146","author":"T Herold","year":"2020","unstructured":"Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, von Bergwelt-Baildon M et al (2020) Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol 146(1):128\u201336.e4","journal-title":"J Allergy Clin Immunol"},{"key":"5630_CR66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cytogfr.2020.05.009","volume":"53","author":"EO Gubernatorova","year":"2020","unstructured":"Gubernatorova EO, Gorshkova EA, Polinova AI, Drutskaya MS (2020) IL-6: relevance for immunopathology of SARS-CoV-2. Cytokine Growth Factor Rev 53:13\u201324","journal-title":"Cytokine Growth Factor Rev"},{"key":"5630_CR67","doi-asserted-by":"publisher","first-page":"118097","DOI":"10.1016\/j.lfs.2020.118097","volume":"257","author":"M Abbasifard","year":"2020","unstructured":"Abbasifard M, Khorramdelazad H (2020) The bio-mission of interleukin-6 in the pathogenesis of COVID-19: a brief look at potential therapeutic tactics. Life Sci 257:118097","journal-title":"Life Sci"},{"issue":"6","key":"5630_CR68","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/1744666X.2021.1919086","volume":"17","author":"N Potere","year":"2021","unstructured":"Potere N, Batticciotto A, Vecchi\u00e9 A, Porreca E, Cappelli A, Abbate A et al (2021) The role of IL-6 and IL-6 blockade in COVID-19. Expert Rev Clin Immunol 17(6):601\u2013618","journal-title":"Expert Rev Clin Immunol"},{"issue":"8","key":"5630_CR69","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","volume":"71","author":"X Chen","year":"2020","unstructured":"Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y et al (2020) Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019. Clin Infect Dis 71(8):1937\u20131942","journal-title":"Clin Infect Dis"},{"issue":"7","key":"5630_CR70","doi-asserted-by":"publisher","first-page":"e12421","DOI":"10.15252\/emmm.202012421","volume":"12","author":"T Liu","year":"2020","unstructured":"Liu T, Zhang J, Yang Y, Ma H, Li Z, Zhang J et al (2020) The role of interleukin-6 in monitoring severe case of coronavirus disease 2019. EMBO Mol Med 12(7):e12421","journal-title":"EMBO Mol Med"},{"issue":"1","key":"5630_CR71","doi-asserted-by":"publisher","first-page":"e20190418","DOI":"10.1084\/jem.20190418","volume":"217","author":"M Saraiva","year":"2020","unstructured":"Saraiva M, Vieira P, O'Garra A (2020) Biology and therapeutic potential of interleukin-10. J Exp Med 217(1):e20190418","journal-title":"J Exp Med"},{"key":"5630_CR72","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal MR, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683\u2013765","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"5630_CR73","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.it.2020.10.012","volume":"42","author":"L Lu","year":"2021","unstructured":"Lu L, Zhang H, Dauphars DJ, He YW (2021) A potential role of interleukin 10 in COVID-19 Pathogenesis. Trends Immunol 42(1):3\u20135","journal-title":"Trends Immunol"},{"issue":"10","key":"5630_CR74","doi-asserted-by":"publisher","first-page":"e592","DOI":"10.1016\/S2665-9913(20)30313-1","volume":"2","author":"B Furlow","year":"2020","unstructured":"Furlow B (2020) COVACTA trial raises questions about tocilizumab\u2019s benefit in COVID-19. Lancet Rheumatol 2(10):e592","journal-title":"Lancet Rheumatol"},{"issue":"1","key":"5630_CR75","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1080\/22221751.2020.1770129","volume":"9","author":"H Han","year":"2020","unstructured":"Han H, Ma Q, Li C, Liu R, Zhao L, Wang W et al (2020) Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect 9(1):1123\u20131130","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"5630_CR76","doi-asserted-by":"publisher","first-page":"e06155","DOI":"10.1016\/j.heliyon.2021.e06155","volume":"7","author":"SK Dhar","year":"2021","unstructured":"Dhar SK, Vishnupriyan K, Damodar S, Gujar S, Das M (2021) IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression. Heliyon 7(2):e06155","journal-title":"Heliyon"},{"key":"5630_CR77","doi-asserted-by":"crossref","unstructured":"Zhao Y, Qin L, Zhang P, Li K, Liang L, Sun J et al (2020) Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight 5(13)","DOI":"10.1172\/jci.insight.139834"},{"issue":"19","key":"5630_CR78","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.jacc.2017.09.024","volume":"70","author":"JI Weitz","year":"2017","unstructured":"Weitz JI, Fredenburgh JC, Eikelboom JW (2017) A test in context: D-dimer. J Am Coll Cardiol 70(19):2411\u20132420","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"5630_CR79","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1182\/blood-2008-06-165845","volume":"113","author":"SS Adam","year":"2009","unstructured":"Adam SS, Key NS, Greenberg CS (2009) D-dimer antigen: current concepts and future prospects. Blood 113(13):2878\u20132887","journal-title":"Blood"},{"issue":"4","key":"5630_CR80","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/jth.12515","volume":"12","author":"AT Cohen","year":"2014","unstructured":"Cohen AT, Spiro TE, Spyropoulos AC, Desanctis YH, Homering M, B\u00fcller HR et al (2014) D-dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial. J Thromb Haemost 12(4):479\u2013487","journal-title":"J Thromb Haemost"},{"issue":"6","key":"5630_CR81","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/ajcp\/102.6.802","volume":"102","author":"KM Rao","year":"1994","unstructured":"Rao KM, Pieper CS, Currie MS, Cohen HJ (1994) Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. Am J Clin Pathol 102(6):802\u2013805","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"5630_CR82","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1378\/chest.121.4.1262","volume":"121","author":"AF Shorr","year":"2002","unstructured":"Shorr AF, Thomas SJ, Alkins SA, Fitzpatrick TM, Ling GS (2002) D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients. Chest 121(4):1262\u20131268","journal-title":"Chest"},{"key":"5630_CR83","doi-asserted-by":"crossref","unstructured":"Lowe GD, Yarnell JW, Rumley A, Bainton D, Sweetnam PM (2001) C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis? Arterioscler Thromb Vasc Biol 21(4):603\u2013610","DOI":"10.1161\/01.ATV.21.4.603"},{"issue":"5","key":"5630_CR84","first-page":"559","volume":"32","author":"Y Xu","year":"2020","unstructured":"Xu Y, Qian Y, Gu Q, Tang J (2020) Relationship between D-dimer concentration and inflammatory factors or organ function in patients with coronavirus disease 2019. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 32(5):559\u2013563","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"1","key":"5630_CR85","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.medin.2020.06.006","volume":"45","author":"G Moreno","year":"2021","unstructured":"Moreno G, Carbonell R, Bod\u00ed M, Rodr\u00edguez A (2021) Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients. Med Intensiva (Engl Ed) 45(1):42\u201355","journal-title":"Med Intensiva (Engl Ed)"},{"key":"5630_CR86","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0065-3233(05)70008-5","volume":"70","author":"JW Weisel","year":"2005","unstructured":"Weisel JW (2005) Fibrinogen and fibrin. Adv Protein Chem 70:247\u2013299","journal-title":"Adv Protein Chem"},{"key":"5630_CR87","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/978-3-319-49674-0_13","volume":"82","author":"JW Weisel","year":"2017","unstructured":"Weisel JW, Litvinov RI (2017) Fibrin formation, structure and properties. Subcell Biochem 82:405\u2013456","journal-title":"Subcell Biochem"},{"issue":"1","key":"5630_CR88","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","volume":"145","author":"M Levi","year":"2009","unstructured":"Levi M, Toh CH, Thachil J, Watson HG (2009) Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 145(1):24\u201333","journal-title":"Br J Haematol"},{"issue":"7","key":"5630_CR89","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1515\/cclm-2020-0188","volume":"58","author":"H Han","year":"2020","unstructured":"Han H, Yang L, Liu R, Liu F, Wu KL, Li J et al (2020) Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med 58(7):1116\u20131120","journal-title":"Clin Chem Lab Med"},{"key":"5630_CR90","doi-asserted-by":"publisher","first-page":"104362","DOI":"10.1016\/j.jcv.2020.104362","volume":"127","author":"D Giannis","year":"2020","unstructured":"Giannis D, Ziogas IA, Gianni P (2020) Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past. J Clin Virol 127:104362","journal-title":"J Clin Virol"},{"issue":"7","key":"5630_CR91","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/jth.14854","volume":"18","author":"M Ranucci","year":"2020","unstructured":"Ranucci M, Ballotta A, Di Dedda U, Baryshnikova E, Dei Poli M, Resta M et al (2020) The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost 18(7):1747\u20131751","journal-title":"J Thromb Haemost"},{"issue":"1","key":"5630_CR92","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0092-8674(87)90669-6","volume":"50","author":"JH Morrissey","year":"1987","unstructured":"Morrissey JH, Fakhrai H, Edgington TS (1987) Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell 50(1):129\u2013135","journal-title":"Cell"},{"issue":"1","key":"5630_CR93","first-page":"66","volume":"86","author":"JH Morrissey","year":"2001","unstructured":"Morrissey JH (2001) Tissue factor: an enzyme cofactor and a true receptor. Thromb Haemost 86(1):66\u201374","journal-title":"Thromb Haemost"},{"issue":"1","key":"5630_CR94","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1055\/s-0040-1722612","volume":"5","author":"W Bauer","year":"2021","unstructured":"Bauer W, Galtung N, Neuwinger N, Kaufner L, Langer E, Somasundaram R et al (2021) A Matter of caution: coagulation parameters in COVID-19 do not differ from patients with ruled-out SARS-CoV-2 infection in the emergency department. TH Open 5(1):e43\u2013e55","journal-title":"TH Open"},{"issue":"10","key":"5630_CR95","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.1073\/pnas.97.10.5255","volume":"97","author":"E Camerer","year":"2000","unstructured":"Camerer E, Huang W, Coughlin SR (2000) Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A 97(10):5255\u20135260","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"5630_CR96","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1538-7836.2009.03368.x","volume":"7 Suppl 1","author":"N Mackman","year":"2009","unstructured":"Mackman N (2009) The many faces of tissue factor. J Thromb Haemost 7 Suppl 1(Suppl 1):136\u2013139","journal-title":"J Thromb Haemost"},{"issue":"9","key":"5630_CR97","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","volume":"118","author":"JH Foley","year":"2016","unstructured":"Foley JH, Conway EM (2016) Cross talk pathways between coagulation and inflammation. Circ Res 118(9):1392\u20131408","journal-title":"Circ Res"},{"issue":"1","key":"5630_CR98","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12959-020-00250-x","volume":"18","author":"Z Eslamifar","year":"2020","unstructured":"Eslamifar Z, Behzadifard M, Soleimani M, Behzadifard S (2020) Coagulation abnormalities in SARS-CoV-2 infection: overexpression tissue factor. Thromb J 18(1):38","journal-title":"Thromb J"},{"issue":"9400","key":"5630_CR99","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0140-6736(03)15012-X","volume":"362","author":"TW Geisbert","year":"2003","unstructured":"Geisbert TW, Hensley LE, Jahrling PB, Larsen T, Geisbert JB, Paragas J et al (2003) Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa\/tissue factor: a study in rhesus monkeys. Lancet 362(9400):1953\u20131958","journal-title":"Lancet"},{"issue":"11","key":"5630_CR100","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1182\/blood.2020007252","volume":"136","author":"ED Hottz","year":"2020","unstructured":"Hottz ED, Azevedo-Quintanilha IG, Palhinha L, Teixeira L, Barreto EA, P\u00e3o CRR et al (2020) Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood 136(11):1330\u20131341","journal-title":"Blood"},{"issue":"2","key":"5630_CR101","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/ATVBAHA.120.315547","volume":"41","author":"A Rosell","year":"2021","unstructured":"Rosell A, Havervall S, von Meijenfeldt F, Hisada Y, Aguilera K, Grover SP et al (2021) Patients with COVID-19 have elevated levels of circulating extracellular vesicle tissue factor activity that is associated with severity and mortality-brief report. Arterioscler Thromb Vasc Biol 41(2):878\u2013882","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"5630_CR102","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1111\/jth.15451","volume":"19","author":"S Subrahmanian","year":"2021","unstructured":"Subrahmanian S, Borczuk A, Salvatore S, Fung KM, Merrill JT, Laurence J, Ahamed J (2021) Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients. J Thromb Haemost 19(9):2268\u20132274","journal-title":"J Thromb Haemost"},{"issue":"1","key":"5630_CR103","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/MBC.0b013e32834cb35d","volume":"23","author":"MI Hassan","year":"2012","unstructured":"Hassan MI, Saxena A, Ahmad F (2012) Structure and function of von Willebrand factor. Blood Coagul Fibrinolysis 23(1):11\u201322","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"5630_CR104","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1538-7836.2009.03653.x","volume":"8","author":"S Li","year":"2010","unstructured":"Li S, Wang Z, Liao Y, Zhang W, Shi Q, Yan R et al (2010) The glycoprotein Ibalpha-von Willebrand factor interaction induces platelet apoptosis. J Thromb Haemost 8(2):341\u2013350","journal-title":"J Thromb Haemost"},{"issue":"5932","key":"5630_CR105","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1126\/science.1170905","volume":"324","author":"X Zhang","year":"2009","unstructured":"Zhang X, Halvorsen K, Zhang CZ, Wong WP, Springer TA (2009) Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science 324(5932):1330\u20131334","journal-title":"Science"},{"issue":"1","key":"5630_CR106","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3324\/haematol.11677","volume":"93","author":"CL Bockmeyer","year":"2008","unstructured":"Bockmeyer CL, Claus RA, Budde U, Kentouche K, Schneppenheim R, L\u00f6sche W et al (2008) Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor. Haematologica 93(1):137\u2013140","journal-title":"Haematologica"},{"issue":"3","key":"5630_CR107","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1172\/JCI112064","volume":"76","author":"LA Sporn","year":"1985","unstructured":"Sporn LA, Chavin SI, Marder VJ, Wagner DD (1985) Biosynthesis of von Willebrand protein by human megakaryocytes. J Clin Invest 76(3):1102\u20131106","journal-title":"J Clin Invest"},{"issue":"5","key":"5630_CR108","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1021\/pr300010r","volume":"11","author":"D van Breevoort","year":"2012","unstructured":"van Breevoort D, van Agtmaal EL, Dragt BS, Gebbinck JK, Dienava-Verdoold I, Kragt A et al (2012) Proteomic screen identifies IGFBP7 as a novel component of endothelial cell-specific Weibel-Palade bodies. J Proteome Res 11(5):2925\u20132936","journal-title":"J Proteome Res"},{"issue":"7","key":"5630_CR109","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1111\/jth.13696","volume":"15","author":"C Kawecki","year":"2017","unstructured":"Kawecki C, Lenting PJ, Denis CV (2017) von Willebrand factor and inflammation. J Thromb Haemost 15(7):1285\u20131294","journal-title":"J Thromb Haemost"},{"issue":"3","key":"5630_CR110","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10238-021-00769-x","volume":"22","author":"M Rostami","year":"2022","unstructured":"Rostami M, Mansouritorghabeh H, Parsa-Kondelaji M (2022) High levels of Von Willebrand factor markers in COVID-19: a systematic review and meta-analysis. Clin Exp Med 22(3):347\u2013357","journal-title":"Clin Exp Med"},{"issue":"10","key":"5630_CR111","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1182\/blood-2002-06-1887","volume":"101","author":"WC Aird","year":"2003","unstructured":"Aird WC (2003) The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101(10):3765\u20133777","journal-title":"Blood"},{"issue":"5","key":"5630_CR112","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s11739-020-02394-0","volume":"15","author":"M Bazzan","year":"2020","unstructured":"Bazzan M, Montaruli B, Sciascia S, Cosseddu D, Norbiato C, Roccatello D (2020) Low ADAMTS 13 plasma levels are predictors of mortality in COVID-19 patients. Intern Emerg Med 15(5):861\u2013863","journal-title":"Intern Emerg Med"},{"issue":"10","key":"5630_CR113","doi-asserted-by":"publisher","first-page":"6704","DOI":"10.1074\/jbc.274.10.6704","volume":"274","author":"J Xu","year":"1999","unstructured":"Xu J, Esmon NL, Esmon CT (1999) Reconstitution of the human endothelial cell protein C receptor with thrombomodulin in phosphatidylcholine vesicles enhances protein C activation. J Biol Chem 274(10):6704\u20136710","journal-title":"J Biol Chem"},{"issue":"12","key":"5630_CR114","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.1016\/S0021-9258(19)70660-7","volume":"255","author":"FJ Walker","year":"1980","unstructured":"Walker FJ (1980) Regulation of activated protein C by a new protein. A possible function for bovine protein S. J Biol Chem 255(12):5521\u20135524","journal-title":"J Biol Chem"},{"issue":"8","key":"5630_CR115","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1182\/blood-2006-09-003004","volume":"109","author":"LO Mosnier","year":"2007","unstructured":"Mosnier LO, Zlokovic BV, Griffin JH (2007) The cytoprotective protein C pathway. Blood 109(8):3161\u20133172","journal-title":"Blood"},{"key":"5630_CR116","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.cca.2019.11.005","volume":"502","author":"J Oto","year":"2020","unstructured":"Oto J, Fernandez-Pardo A, Miralles M, Plana E, Espana F, Navarro S, Medina P (2020) Activated protein C assays: a review. Clin Chim Acta 502:227\u2013232","journal-title":"Clin Chim Acta"},{"key":"5630_CR117","doi-asserted-by":"crossref","unstructured":"Mosnier LO, Griffin JH (2006) Protein C anticoagulant activity in relation to anti-inflammatory and anti-apoptotic activities. Front Biosci 11:2381\u20132399","DOI":"10.2741\/1977"},{"issue":"3 Suppl","key":"5630_CR118","doi-asserted-by":"publisher","first-page":"26s","DOI":"10.1378\/chest.124.3_suppl.26S","volume":"124","author":"CT Esmon","year":"2003","unstructured":"Esmon CT (2003) The protein C pathway. Chest 124(3 Suppl):26s\u201332s","journal-title":"Chest"},{"issue":"21","key":"5630_CR119","doi-asserted-by":"publisher","first-page":"8616","DOI":"10.1074\/jbc.M116.768309","volume":"292","author":"LD Healy","year":"2017","unstructured":"Healy LD, Puy C, Fern\u00e1ndez JA, Mitrugno A, Keshari RS, Taku NA et al (2017) Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo. J Biol Chem 292(21):8616\u20138629","journal-title":"J Biol Chem"},{"issue":"4","key":"5630_CR120","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12185-012-1059-0","volume":"95","author":"JH Griffin","year":"2012","unstructured":"Griffin JH, Zlokovic BV, Mosnier LO (2012) Protein C anticoagulant and cytoprotective pathways. Int J Hematol 95(4):333\u2013345","journal-title":"Int J Hematol"},{"issue":"4","key":"5630_CR121","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/SHK.0000000000001660","volume":"55","author":"MA Mazzeffi","year":"2021","unstructured":"Mazzeffi MA, Chow JH, Tanaka K (2021) COVID-19 associated hypercoagulability: manifestations, mechanisms, and management. Shock 55(4):465\u2013471","journal-title":"Shock"},{"key":"5630_CR122","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.thromres.2021.05.016","volume":"204","author":"TM Stanne","year":"2021","unstructured":"Stanne TM, Pedersen A, Gissl\u00e9n M, Jern C (2021) Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19. Thromb Res 204:13\u201315","journal-title":"Thromb Res"},{"issue":"4","key":"5630_CR123","first-page":"251","volume":"58","author":"LE Stoichitoiu","year":"2020","unstructured":"Stoichitoiu LE, Pinte L, Balea MI, Nedelcu V, Badea C, Baicus C (2020) Anticoagulant protein S in COVID-19: low activity, and associated with outcome. Rom J Intern Med 58(4):251\u2013258","journal-title":"Rom J Intern Med"},{"key":"5630_CR124","doi-asserted-by":"publisher","first-page":"583006","DOI":"10.3389\/fendo.2020.583006","volume":"11","author":"J Hanchard","year":"2020","unstructured":"Hanchard J, Cap\u00f3-V\u00e9lez CM, Deusch K, Lidington D, Bolz SS (2020) Stabilizing cellular barriers: raising the shields against COVID-19. Front Endocrinol (Lausanne) 11:583006","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"5630_CR125","first-page":"346","volume":"86","author":"MS Pepper","year":"2001","unstructured":"Pepper MS (2001) Extracellular proteolysis and angiogenesis. Thromb Haemost 86(1):346\u2013355","journal-title":"Thromb Haemost"},{"issue":"6","key":"5630_CR126","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1172\/JCI111620","volume":"74","author":"EG Levin","year":"1984","unstructured":"Levin EG, Marzec U, Anderson J, Harker LA (1984) Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. J Clin Invest 74(6):1988\u20131995","journal-title":"J Clin Invest"},{"issue":"51","key":"5630_CR127","doi-asserted-by":"publisher","first-page":"51059","DOI":"10.1074\/jbc.M306977200","volume":"278","author":"T Myles","year":"2003","unstructured":"Myles T, Nishimura T, Yun TH, Nagashima M, Morser J, Patterson AJ et al (2003) Thrombin activatable fibrinolysis inhibitor, a potential regulator of vascular inflammation. J Biol Chem 278(51):51059\u201351067","journal-title":"J Biol Chem"},{"issue":"4","key":"5630_CR128","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1055\/s-0037-1613567","volume":"89","author":"K Kolev","year":"2003","unstructured":"Kolev K, Machovich R (2003) Molecular and cellular modulation of fibrinolysis. Thromb Haemost 89(4):610\u2013621","journal-title":"Thromb Haemost"},{"issue":"9","key":"5630_CR129","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","volume":"185","author":"U Amara","year":"2010","unstructured":"Amara U, Flierl MA, Rittirsch D, Klos A, Chen H, Acker B et al (2010) Molecular intercommunication between the complement and coagulation systems. J Immunol 185(9):5628\u20135636","journal-title":"J Immunol"},{"issue":"4","key":"5630_CR130","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18(4):844\u2013847","journal-title":"J Thromb Haemost"},{"issue":"3","key":"5630_CR131","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1152\/physrev.00013.2020","volume":"100","author":"HL Ji","year":"2020","unstructured":"Ji HL, Zhao R, Matalon S, Matthay MA (2020) Elevated plasmin(ogen) as a common risk factor for COVID-19 susceptibility. Physiol Rev 100(3):1065\u20131075","journal-title":"Physiol Rev"},{"issue":"11","key":"5630_CR132","doi-asserted-by":"publisher","first-page":"e7870","DOI":"10.1371\/journal.pone.0007870","volume":"4","author":"YW Kam","year":"2009","unstructured":"Kam YW, Okumura Y, Kido H, Ng LF, Bruzzone R, Altmeyer R (2009) Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro. PLoS One 4(11):e7870","journal-title":"PLoS One"},{"issue":"17","key":"5630_CR133","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1182\/blood-2013-09-526277","volume":"123","author":"S Antoniak","year":"2014","unstructured":"Antoniak S, Mackman N (2014) Multiple roles of the coagulation protease cascade during virus infection. Blood 123(17):2605\u20132613","journal-title":"Blood"},{"issue":"3","key":"5630_CR134","first-page":"1684","volume":"25","author":"RN Gacche","year":"2021","unstructured":"Gacche RN, Gacche RA, Chen J, Li H, Li G (2021) Predictors of morbidity and mortality in COVID-19. Eur Rev Med Pharmacol Sci 25(3):1684\u20131707","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"5630_CR135","first-page":"100","volume":"96","author":"YP Wu","year":"2006","unstructured":"Wu YP, Wei R, Liu ZH, Chen B, Lisman T, Ren DL et al (2006) Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients. Thromb Haemost 96(1):100\u2013101","journal-title":"Thromb Haemost"},{"issue":"12","key":"5630_CR136","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1038\/s41418-020-00633-7","volume":"27","author":"T Matsuyama","year":"2020","unstructured":"Matsuyama T, Kubli SP, Yoshinaga SK, Pfeffer K, Mak TW (2020) An aberrant STAT pathway is central to COVID-19. Cell Death Differ 27(12):3209\u20133225","journal-title":"Cell Death Differ"},{"issue":"5663","key":"5630_CR137","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS et al (2004) Neutrophil extracellular traps kill bacteria. Science 303(5663):1532\u20131535","journal-title":"Science"},{"issue":"7","key":"5630_CR138","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00432-019-02922-2","volume":"145","author":"B Li","year":"2019","unstructured":"Li B, Liu Y, Hu T, Zhang Y, Zhang C, Li T et al (2019) Neutrophil extracellular traps enhance procoagulant activity in patients with oral squamous cell carcinoma. J Cancer Res Clin Oncol 145(7):1695\u20131707","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"5630_CR139","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1083\/jcb.200606027","volume":"176","author":"TA Fuchs","year":"2007","unstructured":"Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, Wahn V et al (2007) Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 176(2):231\u2013241","journal-title":"J Cell Biol"},{"issue":"3","key":"5630_CR140","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1083\/jcb.201006052","volume":"191","author":"V Papayannopoulos","year":"2010","unstructured":"Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A (2010) Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol 191(3):677\u2013691","journal-title":"J Cell Biol"},{"key":"5630_CR141","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.freeradbiomed.2015.10.398","volume":"89","author":"H Bj\u00f6rnsdottir","year":"2015","unstructured":"Bj\u00f6rnsdottir H, Welin A, Micha\u00eblsson E, Osla V, Berg S, Christenson K et al (2015) Neutrophil NET formation is regulated from the inside by myeloperoxidase-processed reactive oxygen species. Free Radic Biol Med 89:1024\u20131035","journal-title":"Free Radic Biol Med"},{"issue":"9","key":"5630_CR142","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1161\/ATVBAHA.114.304114","volume":"34","author":"TJ Gould","year":"2014","unstructured":"Gould TJ, Vu TT, Swystun LL, Dwivedi DJ, Mai SH, Weitz JI, Liaw PC (2014) Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms. Arterioscler Thromb Vasc Biol 34(9):1977\u20131984","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"5630_CR143","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1111\/j.1538-7836.2011.04422.x","volume":"9","author":"CT Ammollo","year":"2011","unstructured":"Ammollo CT, Semeraro F, Xu J, Esmon NL, Esmon CT (2011) Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J Thromb Haemost 9(9):1795\u20131803","journal-title":"J Thromb Haemost"},{"issue":"50","key":"5630_CR144","doi-asserted-by":"publisher","first-page":"35749","DOI":"10.1074\/jbc.M113.509786","volume":"288","author":"S Barranco-Medina","year":"2013","unstructured":"Barranco-Medina S, Pozzi N, Vogt AD, Di Cera E (2013) Histone H4 promotes prothrombin autoactivation. J Biol Chem 288(50):35749\u201335757","journal-title":"J Biol Chem"},{"issue":"6","key":"5630_CR145","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1172\/JCI116151","volume":"90","author":"CB Glaser","year":"1992","unstructured":"Glaser CB, Morser J, Clarke JH, Blasko E, McLean K, Kuhn I et al (1992) Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation. J Clin Invest 90(6):2565\u20132573","journal-title":"J Clin Invest"},{"issue":"4","key":"5630_CR146","first-page":"1659","volume":"61","author":"S Jahr","year":"2001","unstructured":"Jahr S, Hentze H, Englisch S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R (2001) DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61(4):1659\u20131665","journal-title":"Cancer Res"},{"issue":"Pt 3","key":"5630_CR147","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1042\/BJ20041021","volume":"385","author":"F Nakazawa","year":"2005","unstructured":"Nakazawa F, Kannemeier C, Shibamiya A, Song Y, Tzima E, Schubert U et al (2005) Extracellular RNA is a natural cofactor for the (auto-)activation of factor VII-activating protease (FSAP). Biochem J 385(Pt 3):831\u2013838","journal-title":"Biochem J"},{"issue":"15","key":"5630_CR148","doi-asserted-by":"publisher","first-page":"6388","DOI":"10.1073\/pnas.0608647104","volume":"104","author":"C Kannemeier","year":"2007","unstructured":"Kannemeier C, Shibamiya A, Nakazawa F, Trusheim H, Ruppert C, Markart P et al (2007) Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A 104(15):6388\u20136393","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5630_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2003-0025","volume":"26","author":"M Steinhoff","year":"2005","unstructured":"Steinhoff M, Buddenkotte J, Shpacovitch V, Rattenholl A, Moormann C, Vergnolle N et al (2005) Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 26(1):1\u201343","journal-title":"Endocr Rev"},{"key":"5630_CR150","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2741\/1780","volume":"11","author":"S Strukova","year":"2006","unstructured":"Strukova S (2006) Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis. Front Biosci 11:59\u201380","journal-title":"Front Biosci"},{"issue":"12","key":"5630_CR151","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1055\/s-0038-1675603","volume":"118","author":"RN Tunjungputri","year":"2018","unstructured":"Tunjungputri RN, Li Y, de Groot PG, Dinarello CA, Smeekens SP, Jaeger M et al (2018) The inter-relationship of platelets with interleukin-1\u03b2-mediated inflammation in humans. Thromb Haemost 118(12):2112\u20132125","journal-title":"Thromb Haemost"},{"issue":"3","key":"5630_CR152","doi-asserted-by":"publisher","first-page":"102763","DOI":"10.1016\/j.autrev.2021.102763","volume":"20","author":"G Cavalli","year":"2021","unstructured":"Cavalli G, Colafrancesco S, Emmi G, Imazio M, Lopalco G, Maggio MC et al (2021) Interleukin 1\u03b1: a comprehensive review on the role of IL-1\u03b1 in the pathogenesis and treatment of autoimmune and inflammatory diseases. Autoimmun Rev 20(3):102763","journal-title":"Autoimmun Rev"},{"issue":"2","key":"5630_CR153","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/thoraxjnl-2013-204367","volume":"69","author":"RJ Jos\u00e9","year":"2014","unstructured":"Jos\u00e9 RJ, Williams AE, Chambers RC (2014) Proteinase-activated receptors in fibroproliferative lung disease. Thorax 69(2):190\u2013192","journal-title":"Thorax"},{"issue":"1","key":"5630_CR154","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0008-6363(02)00857-X","volume":"60","author":"M Levi","year":"2003","unstructured":"Levi M, Keller TT, van Gorp E, ten Cate H (2003) Infection and inflammation and the coagulation system. Cardiovasc Res 60(1):26\u201339","journal-title":"Cardiovasc Res"},{"issue":"2","key":"5630_CR155","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","volume":"10","author":"X Li","year":"2020","unstructured":"Li X, Geng M, Peng Y, Meng L, Lu S (2020) Molecular immune pathogenesis and diagnosis of COVID-19. J Pharm Anal 10(2):102\u2013108","journal-title":"J Pharm Anal"},{"issue":"5","key":"5630_CR156","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1056\/NEJM200307313490520","volume":"349","author":"G Li","year":"2003","unstructured":"Li G, Chen X, Xu A (2003) Profile of specific antibodies to the SARS-associated coronavirus. N Engl J Med 349(5):508\u2013509","journal-title":"N Engl J Med"},{"key":"5630_CR157","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","volume":"149","author":"M Levi","year":"2017","unstructured":"Levi M, van der Poll T (2017) Coagulation and sepsis. Thromb Res 149:38\u201344","journal-title":"Thromb Res"},{"issue":"7","key":"5630_CR158","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/jth.14869","volume":"18","author":"JF Llitjos","year":"2020","unstructured":"Llitjos JF, Leclerc M, Chochois C, Monsallier JM, Ramakers M, Auvray M, Merouani K (2020) High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost 18(7):1743\u20131746","journal-title":"J Thromb Haemost"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05630-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05630-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05630-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T03:08:01Z","timestamp":1715569681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05630-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,13]]},"references-count":158,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["5630"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05630-1","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,13]]},"assertion":[{"value":"17 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}